Characteristics of comercially available low molecular weight heparins.
| Drug name . | Mean Molecular Wt . | Anti-Xa/ aPTT ratio . | Subcutaneous Treatment Dose (venous thrombosis) . |
|---|---|---|---|
| enoxaparin | 4,300 | 3.8 | 100 anti-Xa IU/kg bid or 150 anti-Xa IU/kg qd |
| dalteparin | 5,800 | 4.0 | 100 anti-Xa IU/kg bid or 200 anti-Xa IU/kg qd |
| tinzaparin | 5,800 | 2.0 | 175 anti Xa IU/kg qd |
| Drug name . | Mean Molecular Wt . | Anti-Xa/ aPTT ratio . | Subcutaneous Treatment Dose (venous thrombosis) . |
|---|---|---|---|
| enoxaparin | 4,300 | 3.8 | 100 anti-Xa IU/kg bid or 150 anti-Xa IU/kg qd |
| dalteparin | 5,800 | 4.0 | 100 anti-Xa IU/kg bid or 200 anti-Xa IU/kg qd |
| tinzaparin | 5,800 | 2.0 | 175 anti Xa IU/kg qd |